Tagra Biotechnologies

📍 New York, United States🗓 Founded 1998👥 28 employees💰 Last funded May 2025
Chemical Raw Materials Manufacturing🌐 tagra.com
Website LinkedIn
Tagra Biotechnologies, since its inception in 1998, focuses on the development and manufacturing of microencapsulated ingredients such as vitamins, oils, sunscreen agents, pigments, and others. Innovation Encapsulated. Beauty Unlocked. Tagra is the first company to patent a unique innovative Release on Demand™ (RND™) Microencapsulation Technology. Tagra’s platform addresses industry challenges of stability, efficiency, and compatibility with other ingredients in cosmetic and pharmaceutical formulations. The technology enables masking, protection, and releases of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagra’s microcapsules are friction released through consumer application. Tagra also owns and operates its own plant and state of the art laboratory meeting all required regulations.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1998
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Tagra Biotechnologies?
Tagra Biotechnologies has 1 investors on record on gritt.io.
When did Tagra Biotechnologies last raise funding?
The most recent investment in Tagra Biotechnologies recorded on gritt.io was in May 2025.
When was Tagra Biotechnologies founded?
Tagra Biotechnologies was founded in 1998.
What industry is Tagra Biotechnologies in?
Tagra Biotechnologies operates in Chemical Raw Materials Manufacturing. Find similar Chemical Raw Materials Manufacturing investors on gritt.io.
Where is Tagra Biotechnologies based?
Tagra Biotechnologies is headquartered in New York, United States.